Gastroenterology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gastroenterology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Endocrinology
Pancreatic beta-cell molecular control of cell cycle progression is reviewed
August 7th, 2006
Molecular control of cell cycle progression in the pancreatic beta-cell is reviewed. According to a recent review from the United States, "Type 1 and type 2 diabetes both result from inadequate production of insulin by the beta-cells of the pancreatic islet. Accordingly, strategies that lead to increased pancreatic beta-cell mass, as well as retained or enhanced function of islets, would be desirable for the treatment of diabetes." I. Cozar-Castellano and colleagues at the University of Pittsburgh summarized, "Although pancreatic beta-cells have long been viewed as terminally differentiated and irreversibly arrested, evidence now indicates that...
Source: Gastroenterology Week (2006-08-07)
|
